Companies: 10,795·Total market cap: $144.5T
Forte Biosciences, Inc.

Forte Biosciences, Inc.

FBRXNASDAQHealthcare● Active
$15.67
$-0.85(-5.15%)
Market Cap$217588919
P/E Ratio
52W High$35.8
52W Low$9.1
Overview

Forte Biosciences, Inc. (FBRX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · FBRX · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-4.58fbrx eps ttm · fbrx earnings per shareEarnings history
PE Ratio (TTM)fbrx pe ratio ttm · fbrx price to earningsPE Ratio deep dive
Revenue (TTM)0.00fbrx revenue ttm · fbrx annual revenueFull revenue history
Dividend YieldNo Dividenddoes fbrx pay dividends · fbrx dividend yieldDividend history
Shares Outstanding147.2Mfbrx shares outstanding · fbrx floatShares outstanding history
Next EarningsAug 13, 2026Est.fbrx earnings date · fbrx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
forte biosciences, inc. revenue · fbrx revenue 2025
FY 2025Net Income-$69.4M▼ 95.54% YoY
202320242025
forte biosciences, inc. net income · fbrx profit 2025
FY 2025EPS$-4.71▲ +61.30% YoY
202320242025
fbrx eps · forte biosciences, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$75.9MEPS: $-4.58View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy6 analystsis fbrx a buy · fbrx analyst rating
Strong Buy
0
Buy
3
Hold
3
Sell
0
Strong Sell
0
12-Month Price Target
$65.00Low
$15.67Current
$65.00Avg Target314.81% upside
$65.00High
fbrx price target · fbrx 12 month forecast

Total: 6 · Buy rate: 50.0%

The FBRX analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $65.00, representing +314.81% upside from the current price of $15.67.

Stock Performance

Full History
1D-5.15%
1W-13.81%
1M-34.76%
3M-45.51%
YTD-42.54%
1Y+31.13%
5Y-98.52%

About Forte Biosciences, Inc.

CEOPaul A. Wagner
IPO DateApr 13, 2017
Employees14
CountryUS

Forte Biosciences, Inc. is a U.S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tac…

what is forte biosciences, inc. · fbrx stock overview · forte biosciences, inc. company profile · who is forte biosciences, inc. ceo · fbrx NASDAQ · forte biosciences, inc. headquarters · forte biosciences, inc. business segments

About Stock Overview & Key Data

Forte Biosciences, Inc. (FBRX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 13, 2017. As of the latest trading session, FBRX stock price is $15.67, with a market capitalization of $217.6M. The stock has returned +31.13% over the past 12 months and -42.54% year-to-date.

According to 6 Wall Street analysts, the consensus rating for Forte Biosciences, Inc. stock is Buy, with an average 12-month price target of $65.00. In fiscal year 2025, Forte Biosciences, Inc. reported revenue of — and net income of -$69.4M. For detailed data — including Forte Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Forte Biosciences, Inc. (FBRX) stock price is $15.67. The stock is traded on NASDAQ under the ticker symbol FBRX. The 52-week range is $9.10 – $35.80.

FBRX stock priceFBRX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice